Russia has completed their phase 2 vaccine trials with the help of the Russian defence ministry. The vaccine is now ready to use in Russia. First Deputy Defense Minister Ruslan Tsalikov to say the first domestic inoculation is ready for use.
The army is developing a vaccine with the state-run Gamaleya Institute in Moscow and the Russian Direct Investment Fund. Phase 3 trials, of people in Russia, Saudi Arabia and the United Arab Emirates. They are to begin Aug 3rd and distribution of the vaccine will start as early as September, RDIF’s head Kirill Dmitriev said last week.
Russia could make 30 million doses domestically in 2020, and 170 million abroad, with five countries expressing interest in producing the vaccine and others willing to produce it, according to Dmitriev.
The Defense Ministry did not immediately respond to a request for comment. Tests of the vaccine is continuing. The Interfax news service reported, citing the Health Ministry in response to the statement.